MODULITH SLC for CSWT

Cardiac shock wave therapy (CSWT) for non-invasive treatment of ischaemic heart diseases such as angina pectoris.

Among cardiovascular diseases, ischaemic heart disease is the most common cause of death in industrialized nations. Although medication or interventional procedures provide good results in the treatment of systolic heart failure, these therapies are not suitable for all affected patients due to the extra strain they put on the body. When treating diastolic heart failure, in particular, the medication and therapies available today are ineffective.

Non-invasive cardiac shock wave therapy performed on an outpatient basis provides a significant improvement of angina pectoris (graded according to the NYHA and CCS classification) while at the same time increasing physical performance capability. Being a gentle treatment method with hardly any complications, CSWT can also be performed on risk patients to improve their quality of life (assessed through the SAQ) in the long term (results obtained over a 6-years follow-up period).